|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Merck & Co. Inc. (MRK)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-12 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
73,727 | $78.62 | $5,796,306 | 125,194 (Direct) |
View |
| 2019-02-13 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $78.71 | $393,548 | 5,100 (Direct) |
View |
| 2019-02-14 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
64,662 | $78.96 | $5,105,951 | 80,837 (Direct) |
View |
| 2019-02-08 Sale |
2019-02-11 5:33 pm |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
3,052 | $77.22 | $235,681 | 5,000 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-06 5:30 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $78.08 | $18,079,654 | 923,516 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-04 5:44 pm |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
10,000 | $75.96 | $759,590 | 15,100 (Direct) |
View |
| 2018-11-07 Sale |
2018-11-08 4:31 pm |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $75.14 | $2,721,348 | 82,481 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-08 4:31 pm |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $75.26 | $16,967,967 | 366,998 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-02 4:44 pm |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $73.81 | $20,510,944 | 277,879 (Indirect Direct) |
View |
| 2018-10-30 Sale |
2018-11-01 5:07 pm |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $72 | $1,833,739 | 82,135 (Indirect Direct) |
View |
| 2018-10-31 Sale |
2018-11-01 5:07 pm |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
47,036 | $74.33 | $3,496,158 | 56,806 (Indirect Direct) |
View |
| 2018-10-02 Sale |
2018-10-03 5:26 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,850 | $72.07 | $20,168,258 | 971,800 (Indirect Direct) |
View |
| 2018-10-01 Purchase |
2018-10-02 2:31 pm |
SUTRO BIOPHARMA INC | STRO | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
666,666 | $15 | $9,999,990 | 2,723,509 (Indirect) |
View |
| 2018-09-18 Sale |
2018-09-19 5:43 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,851 | $70.08 | $19,611,818 | 971,801 (Indirect Direct) |
View |
| 2018-09-17 Sale |
2018-09-18 4:49 pm |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
107,360 | $70.18 | $7,534,291 | 100,000 (Direct Indirect) |
View |
| 2018-08-03 Sale |
2018-08-06 4:49 pm |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
29,208 | $65.2 | $1,904,362 | 80,675 (Direct) |
View |
| 2018-08-02 Sale |
2018-08-02 5:07 pm |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
5,000 | $65.01 | $325,040 | 16,175 (Direct) |
View |
| 2018-07-31 Sale |
2018-08-01 5:12 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
228,091 | $65 | $14,826,691 | 938,788 (Indirect Direct) |
View |
| 2018-06-18 Sale |
2018-06-19 10:55 am |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
134,094 | $61 | $8,179,945 | 100,000 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
43,876 | $39.29 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
29,851 | $36.56 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
43,876 | $39.29 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
29,851 | $36.56 | 125,194 (Direct) |
View |
| 2019-02-13 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $24.3 | 5,100 (Direct) |
View |
| 2019-02-13 Exercise |
2019-02-14 6:02 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $24.3 | 5,100 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
37,152 | $59.86 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
27,510 | $58.22 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
2016-05-01 2025-04-30 |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
37,152 | $59.86 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
2015-05-09 2024-05-08 |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
27,510 | $58.22 | 80,837 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 5:33 pm |
N/A N/A |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
5,000 | $24.3 | 5,000 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 5:33 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
5,000 | $24.3 | 5,000 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-06 5:30 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $39.29 | 923,516 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-06 5:30 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $39.29 | 923,516 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $35.19 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $24.3 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $24.3 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
2011-08-04 2020-08-03 |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $35.19 | 15,100 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
376 | $76.41 | 86,461 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
376 | $76.41 | 85,416 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | THULIN INGE G Director |
376 | $76.41 | 4,887 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Noseworthy John H Director |
376 | $76.41 | 8,818 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | LAZARUS ROCHELLE B Director |
376 | $76.41 | 80,689 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:25 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
442 | $76.41 | 62,242 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 4:31 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $54.68 | 82,481 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 4:31 pm |
2017-05-10 2026-05-09 |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $54.68 | 82,481 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-08 4:31 pm |
N/A N/A |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $44.98 | 366,998 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-08 4:31 pm |
2014-05-06 2023-05-05 |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $44.98 | 366,998 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 4:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $39.29 | 277,879 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 4:44 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $39.29 | 277,879 (Direct) |
View |
| 2018-10-30 Exercise |
2018-11-01 5:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $34.19 | 82,135 (Direct) |
View |
| 2018-10-30 Exercise |
2018-11-01 5:07 pm |
2012-11-02 2021-11-01 |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $34.19 | 82,135 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
23,220 | $59.86 | 56,806 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
18,110 | $54.68 | 56,806 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
5,706 | $63.97 | 56,806 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
2016-05-01 2025-04-30 |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
23,220 | $59.86 | 56,806 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
2018-05-05 2027-05-04 |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
5,706 | $63.97 | 56,806 (Direct) |
View |
| 2018-10-31 Exercise |
2018-11-01 5:07 pm |
2017-05-10 2026-05-09 |
Merck & Co. Inc. | MRK | Watson Ashley CEO |
18,110 | $54.68 | 56,806 (Direct) |
View |
| 2018-10-30 Option Award |
2018-11-01 5:05 pm |
2019-10-30 2021-10-30 |
Merck & Co. Inc. | MRK | MIZELL STEVEN VP |
13,723 | $0 | 51,252 (Direct) |
View |
| 2018-10-30 Option Award |
2018-11-01 5:05 pm |
2019-10-30 2028-10-29 |
Merck & Co. Inc. | MRK | MIZELL STEVEN VP |
51,252 | $72.87 | 51,252 (Direct) |
View |
| 2018-10-30 Option Award |
2018-11-01 5:03 pm |
2019-10-30 2021-10-30 |
Merck & Co. Inc. | MRK | Scholefield James H CIO |
34,308 | $0 | 47,456 (Direct) |
View |
| 2018-10-30 Option Award |
2018-11-01 5:03 pm |
2019-10-30 2028-10-29 |
Merck & Co. Inc. | MRK | Scholefield James H CIO |
47,456 | $72.87 | 47,456 (Direct) |
View |
| 2018-10-02 Exercise |
2018-10-03 5:26 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,850 | $36.56 | 971,800 (Direct) |
View |
| 2018-10-02 Exercise |
2018-10-03 5:26 pm |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,850 | $36.56 | 971,800 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:39 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
405 | $70.94 | 85,510 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:39 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
405 | $70.94 | 84,471 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:39 pm |
N/A N/A |
Merck & Co. Inc. | MRK | THULIN INGE G Director |
405 | $70.94 | 4,483 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:39 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Noseworthy John H Director |
405 | $70.94 | 8,388 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:38 pm |
N/A N/A |
Merck & Co. Inc. | MRK | LAZARUS ROCHELLE B Director |
405 | $70.94 | 79,776 (Direct) |
View |
| 2018-09-28 Option Award |
2018-10-02 4:38 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
476 | $70.94 | 61,389 (Direct) |
View |
| 2018-10-01 Conversion |
2018-10-02 2:31 pm |
N/A N/A |
SUTRO BIOPHARMA INC | STRO | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
2,056,843 | $0 | 2,723,509 (Indirect) |
View |
| 2018-10-01 Conversion |
2018-10-02 2:31 pm |
N/A N/A |
SUTRO BIOPHARMA INC | STRO | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
74,794,312 | $0 | 2,723,509 (Indirect) |
View |
| 2018-09-18 Exercise |
2018-09-19 5:43 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,851 | $36.56 | 971,801 (Direct) |
View |
| 2018-09-18 Exercise |
2018-09-19 5:43 pm |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
279,851 | $36.56 | 971,801 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-18 4:49 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
100,000 | $36.56 | 100,000 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-18 4:49 pm |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
100,000 | $36.56 | 100,000 (Direct) |
View |
| 2018-08-03 Exercise |
2018-08-06 4:49 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
19,208 | $33.49 | 80,675 (Direct) |
View |
| 2018-08-03 Exercise |
2018-08-06 4:49 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
10,000 | $37.49 | 80,675 (Direct) |
View |
| 2018-08-03 Exercise |
2018-08-06 4:49 pm |
2011-02-19 2020-02-18 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
10,000 | $37.49 | 80,675 (Direct) |
View |
| 2018-08-03 Exercise |
2018-08-06 4:49 pm |
2011-05-07 2020-05-06 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
19,208 | $33.49 | 80,675 (Direct) |
View |
| 2018-07-31 Exercise |
2018-08-01 5:12 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
228,091 | $33.49 | 938,788 (Direct) |
View |
| 2018-07-31 Gift |
2018-08-01 5:12 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
18,747 | $0 | 938,788 (Direct) |
View |
| 2018-07-31 Exercise |
2018-08-01 5:12 pm |
2011-05-07 2020-05-06 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
228,091 | $33.49 | 938,788 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
474 | $60.7 | 84,455 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
474 | $60.7 | 83,424 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | THULIN INGE G Director |
474 | $60.7 | 4,051 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:06 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Noseworthy John H Director |
474 | $60.7 | 7,925 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:06 pm |
N/A N/A |
Merck & Co. Inc. | MRK | LAZARUS ROCHELLE B Director |
474 | $60.7 | 78,765 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-02 12:06 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
556 | $60.7 | 60,449 (Direct) |
View |
| 2018-06-18 Exercise |
2018-06-19 10:55 am |
N/A N/A |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
100,000 | $36.56 | 100,000 (Direct) |
View |
| 2018-06-18 Exercise |
2018-06-19 10:55 am |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
100,000 | $36.56 | 100,000 (Direct) |
View |
| 2018-05-25 Option Award |
2018-05-29 5:33 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
3,131 | $59.09 | 83,981 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 17 Feb 2019 20:13:08 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |